Loading organizations...
§ Private Profile · Nazareth Illit, HaZafon, Israel
medical device company developing a transcatheter procedure for heart failure patients, focused on reshaping the ventricle to treat HFrEF.
Based in Yokneam, Israel, Cardiac Success is a medical device company that develops an innovative transcatheter procedure to treat heart failure with reduced ejection fraction by directly reshaping the ventricle. The proprietary V-sling system is designed to halt heart deterioration, reduce symptoms, and initiate cardiac recovery without relying on traditional surgical interventions. Founded in 2017 within the Alon Medtech Ventures incubator by Shimon Eckhouse and David Neustadter, the enterprise is guided by executives Boaz Manash and Rafael Beyar, who bring extensive prior experience from Edwards Lifesciences and the Rambam Medical Center. The growing venture successfully secured $5.2 million in Series A financing led by 415 CAPITAL alongside a strategic partner in June 2021. Proceeds from this recent funding round are currently directed toward advancing preclinical testing and executing first-in-human clinical trials for their novel cardiology technology.
Cardiac Success has raised $16.6M across 2 funding rounds.
Cardiac Success has raised $16.6M in total across 2 funding rounds.
Cardiac Success has raised $16.6M in total across 2 funding rounds.
Cardiac Success's investors include European Innovation Council, 415 Capital.
Cardiac Success has raised $16.6M across 2 funding rounds. Most recently, it raised $11.4M Grant / Other Equity in January 2022.
| Date | Round | Lead Investors | Other Investors | Status |
|---|---|---|---|---|
| Jan 12, 2022 | $11.4M Grant | European Innovation Council | — | Announced |
| Jun 24, 2021 | $5.2M Series A | 415 Capital | — | Announced |